Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche
暂无分享,去创建一个
Nicola Giuliani | Cristina Mancini | Fabio Morandi | Ilaria Roato | Vito Pistoia | G. Faccani | C. Mancini | F. Malavasi | V. Pistoia | D. Marimpietri | A. Horenstein | Danilo Marimpietri | N. Giuliani | F. Morandi | Fabio Malavasi | Giuliano Faccani | Marina Bolzoni | Valeria Quarona | Valentina Ferri | Antonella Chillemi | Gianluca Zaccarello | Eugenia Martella | Alberto L Horenstein | M. Bolzoni | E. Martella | V. Ferri | A. Chillemi | V. Quarona | I. Roato | G. Zaccarello | Alberto L. Horenstein
[1] S. Jalkanen,et al. Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase‐1 and NTPDase1/CD39 activities , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] D. Friedman,et al. CD39 and control of cellular immune responses , 2007, Purinergic Signalling.
[3] Eva C. Arnspang,et al. Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells , 2013, The Journal of Immunology.
[4] M. Kikuchi,et al. CD38 gene knockout juvenile mice: a model of oxytocin signal defects in autism. , 2011, Biological & pharmaceutical bulletin.
[5] N. Scrutton,et al. Crystal Structure of a Soluble Form of Human CD73 with Ecto‐5′‐Nucleotidase Activity , 2012, Chembiochem : a European journal of chemical biology.
[6] J. Schrader,et al. Formation of S-adenosylhomocysteine in the heart. I: An index of free intracellular adenosine. , 1988, Circulation research.
[7] Pál Pacher,et al. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases , 2006, Nature Reviews Drug Discovery.
[8] L. Antonioli,et al. Immunity, inflammation and cancer: a leading role for adenosine , 2013, Nature Reviews Cancer.
[9] Purinergic signalling in endocrine organs , 2014, Purinergic Signalling.
[10] S. Deaglio,et al. CD38 and CD157 as Receptors of the Immune System: A Bridge Between Innate and Adaptive Immunity , 2006, Molecular medicine.
[11] B. Cronstein,et al. Adenosine and bone metabolism , 2013, Trends in Endocrinology & Metabolism.
[12] J. Goding,et al. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. , 2003, Biochimica et biophysica acta.
[13] Silvia Deaglio,et al. CD38 and chronic lymphocytic leukemia: a decade later. , 2011, Blood.
[14] D. Rossi,et al. E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia , 2011, Leukemia.
[15] T. Whiteside,et al. Adenosine production by human B cells and B cell-mediated suppression of activated T cells. , 2013, Blood.
[16] T. Yoshino,et al. Effect of adenosine receptor subtypes stimulation on mixed lymphocyte reaction. , 2007, European journal of pharmacology.
[17] N. Nassif,et al. Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma , 2014, Leukemia & lymphoma.
[18] J. Laubach,et al. Daratumumab granted breakthrough drug status , 2014, Expert opinion on investigational drugs.
[19] M. Ferracin,et al. Anti-CD38 Antibody Therapy: Windows of Opportunity Yielded by the Functional Characteristics of the Target Molecule , 2013, Molecular Medicine.
[20] J. Sévigny,et al. The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2. , 2001, European journal of biochemistry.
[21] B. Fredholm,et al. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update , 2011, Pharmacological Reviews.
[22] W. Junger,et al. Immune cell regulation by autocrine purinergic signalling , 2011, Nature Reviews Immunology.
[23] G. Storm,et al. Human Regulatory T Cells Do Not Suppress the Antitumor Immunity in the Bone Marrow: A Role for Bone Marrow Stromal Cells in Neutralizing Regulatory T Cells , 2013, Clinical Cancer Research.
[24] G. Mundy,et al. Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells , 2012, PloS one.
[25] A. Mackensen,et al. A humanized mouse identifies the bone marrow as a niche with low therapeutic IgG activity. , 2014, Cell reports.
[26] R. Ebstein,et al. Are retinoids potential therapeutic agents in disorders of social cognition including autism? , 2011, FEBS letters.
[27] J. Baldwin,et al. Structure and function of receptors coupled to G proteins. , 1994, Current opinion in cell biology.
[28] R. Graeff,et al. ADP-ribosyl Cyclase and CD38 Catalyze the Synthesis of a Calcium-mobilizing Metabolite from NADP+(*) , 1995, The Journal of Biological Chemistry.
[29] M. Chilosi,et al. Human myeloma cells express the CD38 ligand CD31 , 1999, British journal of haematology.
[30] R. Senetta,et al. Contribution of adenosine-producing ectoenzymes to the mechanisms underlying the mitigation of maternal-fetal conflicts. , 2013, Journal of biological regulators and homeostatic agents.
[31] S. Toyosawa,et al. CD73‐generated adenosine promotes osteoblast differentiation , 2012, Journal of cellular physiology.
[32] O. Garson,et al. Plasma cell membrane glycoprotein PC-1. cDNA cloning of the human molecule, amino acid sequence, and chromosomal location. , 1990, The Journal of biological chemistry.
[33] Makoto Sato,et al. Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease , 2014, Front. Behav. Neurosci..
[34] Ying Zhao,et al. E proteins regulate osteoclast maturation and survival , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[35] S. Deaglio,et al. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. , 2008, Physiological reviews.
[36] M. Pastor-Anglada,et al. Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling , 2007, Journal of Physiology and Biochemistry.
[37] S. Colgan,et al. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. , 2009, Blood.
[38] M. Doucet,et al. Enpp1: A Potential Facilitator of Breast Cancer Bone Metastasis , 2013, PloS one.
[39] Linheng Li,et al. The stem cell niches in bone. , 2006, The Journal of clinical investigation.
[40] J. Klawitter,et al. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. , 2017, The Journal of clinical investigation.
[41] T. Yuen,et al. Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts. , 2011, Biochemical and biophysical research communications.
[42] S. Colgan,et al. Crucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia , 2004, The Journal of experimental medicine.
[43] M. Howard,et al. Ecto‐enzymes of lymphoid cells , 1998, Immunological reviews.
[44] J. Goding. Ecto‐enzymes: physiology meets pathology , 2000, Journal of leukocyte biology.
[45] L. Rybak,et al. Adenosine Receptors: Expression, Function and Regulation , 2014, International journal of molecular sciences.
[46] T. Yuen,et al. Bone Marrow Oxytocin Mediates the Anabolic Action of Estrogen on the Skeleton* , 2012, The Journal of Biological Chemistry.
[47] V. Kuchroo,et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39 , 2013, Nature Immunology.
[48] Bin Zhang. CD73 promotes tumor growth and metastasis , 2012, Oncoimmunology.
[49] D. Wiest,et al. The TCR ligand-inducible expression of CD73 marks γδ lineage commitment and a metastable intermediate in effector specification , 2014, The Journal of experimental medicine.
[50] M. Sitkovsky,et al. Purinergic signaling during inflammation. , 2012, The New England journal of medicine.
[51] Laurens P. Kil,et al. Targeting Bruton's tyrosine kinase in B cell malignancies , 2014, Nature Reviews Cancer.
[52] F. Malavasi,et al. CD38 and bone marrow microenvironment. , 2014, Frontiers in bioscience.
[53] F. Malavasi,et al. Exosomes from human lymphoblastoid B cells express enzymatically active CD38 that is associated with signaling complexes containing CD81, Hsc-70 and Lyn. , 2010, Experimental cell research.
[54] N. Hatch,et al. Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) Protein Regulates Osteoblast Differentiation , 2011, The Journal of Biological Chemistry.
[55] T. Gudermann,et al. The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. , 2002, Reviews of physiology, biochemistry and pharmacology.
[56] H. Nishimasu,et al. Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling , 2012, Proceedings of the National Academy of Sciences.
[57] F. Malavasi,et al. A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes , 2013, Oncoimmunology.
[58] J. Eliaou,et al. ENTPD1/CD39 is a promising therapeutic target in oncology , 2013, Oncogene.
[59] L. Old,et al. SURFACE ALLOANTIGENS OF PLASMA CELLS , 1970, The Journal of experimental medicine.
[60] R. Parkhouse,et al. Location of nucleotide pyrophosphatase and alkaline phosphodiesterase activities on the lymphocyte surface membrane. , 1976, The Biochemical journal.
[61] N. Munshi,et al. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans. , 2013, Blood.
[62] J. Stagg. The double-edge sword effect of anti-CD73 cancer therapy , 2012, Oncoimmunology.
[63] T. Seike,et al. CD38 is critical for social behaviour by regulating oxytocin secretion , 2007, Nature.
[64] T. Yuen,et al. The Oxytocin–Bone Axis , 2014, Journal of neuroendocrinology.
[65] E. Vizi,et al. CD39 and CD73 in immunity and inflammation. , 2013, Trends in molecular medicine.
[66] F. Malavasi,et al. CD38 and CD157: A long journey from activation markers to multifunctional molecules , 2013, Cytometry. Part B, Clinical cytometry.
[67] A. Uccelli,et al. Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.
[68] B. Ryffel,et al. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. , 2012, Immunity.